<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03100422</url>
  </required_header>
  <id_info>
    <org_study_id>Multi VIT-ARMin</org_study_id>
    <nct_id>NCT03100422</nct_id>
  </id_info>
  <brief_title>Strategies of Therapy With the Exoskeleton Robot ARMin</brief_title>
  <acronym>MultiVIT-ARMin</acronym>
  <official_title>Strategies of Therapy With the Exoskeleton Robot ARMinMulti VIT-ARMin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swiss Federal Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rehaklinik Zihlschlacht AG</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Swiss Federal Institute of Technology</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neurological patients (e.g., after stroke) need long-term neurorehabilitation therapy of the&#xD;
      arm with often limited, unsatisfactory outcome. Robots became a promising supplement or even&#xD;
      alternative for neurorehabilitation training.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The exoskeleton robot ARMin was further developed and software components adapted accordingly&#xD;
      to offer a unique intensified and patient-tailored robot-aided training of the arm. The goal&#xD;
      is to enhance treatment efficacy to an extent that the improvement in motor function is&#xD;
      meaningful for the individual patient. The study objective is to compare ARMin therapy and a&#xD;
      form of conventional occupational therapy that involves both arms regarding change in motor&#xD;
      function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2017</start_date>
  <completion_date type="Actual">October 31, 2018</completion_date>
  <primary_completion_date type="Actual">October 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Lots will be drawn that assign to either robotic therapy or occupational therapy</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl Meyer Assessment, upper extremity motor function</measure>
    <time_frame>from baseline to day 3 post-training</time_frame>
    <description>impairment based clinical test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ARMin assessment time</measure>
    <time_frame>from baseline to day 3 post-training</time_frame>
    <description>time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ARMin assessment torques</measure>
    <time_frame>from baseline to day 3 post-training</time_frame>
    <description>torques</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ARMin assessment positions</measure>
    <time_frame>from baseline to day 3 post-training</time_frame>
    <description>positions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intrinsic Motivation Inventory</measure>
    <time_frame>from baseline to day 3 post-training</time_frame>
    <description>questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor Activity Log</measure>
    <time_frame>from baseline to day 3 post-training</time_frame>
    <description>questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>handheld dynamometer</measure>
    <time_frame>from baseline to day 3 post-training</time_frame>
    <description>isometric strength</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>ARMin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Therapy with the arm therapy robot ARMin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm+ occupational therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>a form of conventional occupational therapy that involves both arms</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ARMin</intervention_name>
    <description>arm therapy robot</description>
    <arm_group_label>ARMin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Occupational Therapy</intervention_name>
    <description>bilateral arm training</description>
    <arm_group_label>Arm+ occupational therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  - Aged ≥18 years&#xD;
&#xD;
          -  Ischemic cerebral vascular accident (CVA, stroke) in the sub-acute phase (one to&#xD;
             twelve weeks post-stroke) as verified by brain imaging (CT or MRI)&#xD;
&#xD;
          -  Inpatient at Rehaklinik Zihlschlacht, Switzerland&#xD;
&#xD;
          -  Decreased arm motor function in one arm with a FMA of 8 to 20 points (out of 66)&#xD;
&#xD;
          -  No excessive spasticity of the affected arm (modified Ashworth Scale mAS ≤3) as&#xD;
             assessed by the physician&#xD;
&#xD;
          -  No serious medical or psychiatric disorder as assessed by the physician&#xD;
&#xD;
          -  No serious orthopaedic, rheumatologic or other disease restricting movements of the&#xD;
             paretic arm as assessed by the physician&#xD;
&#xD;
          -  No clinically significant shoulder subluxation (palpation &lt;2 fingers) as assessed by&#xD;
             the physician&#xD;
&#xD;
          -  No skin ulcerations at the paretic arm as assessed by the physician&#xD;
&#xD;
          -  Ability to communicate effectively with the examiner such that the validity of the&#xD;
             patient's data could not be compromised as assessed by the physician&#xD;
&#xD;
          -  No history of cyber sickness (e.g., nausea when looking at a screen or playing&#xD;
             computer games) as assessed by the physician&#xD;
&#xD;
          -  No pacemaker or other implanted electric device as verified by patient record&#xD;
&#xD;
          -  Bodyweight &lt;120 kg&#xD;
&#xD;
          -  No serious cognitive defects or aphasia preventing effective use of ARMin as assessed&#xD;
             by the physician&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Riener, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>ETH Zurich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Labor für Sensomotorische Systeme, ETH Zürich, Balgrist Campus</name>
      <address>
        <city>Zürich</city>
        <zip>8002</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>February 14, 2017</study_first_submitted>
  <study_first_submitted_qc>March 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>July 15, 2020</last_update_submitted>
  <last_update_submitted_qc>July 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Armin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

